Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Shun Yen

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Journal of Diabetes Investigation|November 7, 2024
LX9211, a rising star for relieving of diabetic peripheral neuropathic painChia-Chin Lee, Fu-Shun Ko, Fu-Shun Yen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 16, 2026
Divergent Risks of Endocrine and Non-Endocrine Malignancies in GLP-1 Receptor Agonist Users: A Propensity-Matched Real-World Analysis of Over 140,000 PatientsCheng-Hsien Hung, Fu-Shun Yen, Jing-Yang Huang, et al.
Diabetes Research and Clinical Practice|May 8, 2023
Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitusFu-Shun Yen, Shiow-Ing Wang, Shih-Yi Lin, et al.
International Journal of Rheumatic Diseases|April 11, 2025
Glucagon-Like Peptide-1 Receptor Agonists: Multifaceted Roles in Immune and Inflammatory Regulation, Glycemic Control, and Synergistic Therapeutic ApplicationsChia-Chien Hsu, Chi-Jen Hsu, Xiangpei Fang, et al.
International Journal of Rheumatic Diseases|April 14, 2025
Anti-Inflammatory Mechanisms of Antidiabetic Therapies: Metabolic Regulation and Inflammatory PathwaysFu-Shun Yen, Yung-Heng Lee, Poi Kuo, et al.
Frontiers in Medicine|January 23, 2023
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetesFu-Shun Yen, Ming-Chih Hou, Jia-Sin Liu, et al.
Plos One|October 5, 2018
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject designFu-Shun Yen, Weishan Chen, James Cheng-Chung Wei, et al.
Blood Pressure|November 20, 2020
Serum uric acid and blood pressure among adolescents: data from the Nutrition and Health Survey in Taiwan (NAHSIT) 2010-2011Kuan-Hung Lin, Fu-Shun Yen, Harn-Shen Chen, et al.
BMC Endocrine Disorders|February 19, 2021
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Mei-Chen Lin, et al.
Journal of Medical Virology|November 4, 2022
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Hei-Tung Yip, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Journal of Diabetes Investigation|November 7, 2024
LX9211, a rising star for relieving of diabetic peripheral neuropathic painChia-Chin Lee, Fu-Shun Ko, Fu-Shun Yen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 16, 2026
Divergent Risks of Endocrine and Non-Endocrine Malignancies in GLP-1 Receptor Agonist Users: A Propensity-Matched Real-World Analysis of Over 140,000 PatientsCheng-Hsien Hung, Fu-Shun Yen, Jing-Yang Huang, et al.
Diabetes Research and Clinical Practice|May 8, 2023
Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitusFu-Shun Yen, Shiow-Ing Wang, Shih-Yi Lin, et al.
International Journal of Rheumatic Diseases|April 11, 2025
Glucagon-Like Peptide-1 Receptor Agonists: Multifaceted Roles in Immune and Inflammatory Regulation, Glycemic Control, and Synergistic Therapeutic ApplicationsChia-Chien Hsu, Chi-Jen Hsu, Xiangpei Fang, et al.
International Journal of Rheumatic Diseases|April 14, 2025
Anti-Inflammatory Mechanisms of Antidiabetic Therapies: Metabolic Regulation and Inflammatory PathwaysFu-Shun Yen, Yung-Heng Lee, Poi Kuo, et al.
Frontiers in Medicine|January 23, 2023
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetesFu-Shun Yen, Ming-Chih Hou, Jia-Sin Liu, et al.
Plos One|October 5, 2018
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject designFu-Shun Yen, Weishan Chen, James Cheng-Chung Wei, et al.
Blood Pressure|November 20, 2020
Serum uric acid and blood pressure among adolescents: data from the Nutrition and Health Survey in Taiwan (NAHSIT) 2010-2011Kuan-Hung Lin, Fu-Shun Yen, Harn-Shen Chen, et al.
BMC Endocrine Disorders|February 19, 2021
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Mei-Chen Lin, et al.
Journal of Medical Virology|November 4, 2022
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Hei-Tung Yip, et al.
Pageof 11